This website protects your privacy by adhering to the European Union General Data Protection Regulation (GDPR). We will not use your data for any purpose that you do not consent to and only to the extent not exceeding data which is necessary in relation to a specific purpose(s) of processing. You can grant your consent(s) to use your data for specific purposes below or by clicking “Agree to all”.
Find out about the winning journalism projects of our new grant programme
The new French government has defined health as one of the five main areas of action in national development aid. Funding of NGOs working in these areas will double until 2022.* However, the activities of French organisations to improve health and healthcare in development countries have not been covered much by French media.
To increase the scope and depth of global health reporting in France, the European Journalism Centre has awarded 10 projects that will raise awareness of this under-reported topic.
The reportages featuring health topics will inform and engage the general public, influencers and decision makers in government, industry, and medical communities as well as the generation of “millennials”.
Reported from 14 different countries, the diverse audiences of at least 17 different media outlets in France will learn about new angles of global health issues regarding risks, lessons learned and potential solutions. Publications will range from large traditional media such as Le Monde, Le Figaro, Paris Match, to online media such as Slate.fr, Loopsider and The Conversations.
These are the projects that offer surprising or investigative approaches and unseen topics around global health:
Cancer is a killer disease, especially in developing countries, where 70% of deaths caused by cancer result from the lack of prevention and access to healthcare, as well as limited knowledge of the nature and spread of the disease. Still, there are positive signs. 20 development countries have committed themselves to create national registers of cancer by 2020 — a measure that has only been partially implemented by France to date. It’s an epidemiological lesson that gives food for thought to the French government.
Team: Viviane Thivent (journalist), Julien Goldstein (photographer)
Locations: India, El Salvador, DR Congo
Media outlet: Le Monde
Budget: 20,000€
In 2015, the French laboratory Sanofi launched a vaccine against dengue fever — a world premiere. But soon the safety of the vaccine was put to question by the suspicious deaths of several children in the Philippines. Sanofi has evaluated the results and admitted the potential dangers of the vaccine, while families claim they have been used as test subjects. However, this scandal could spark the development of better vaccines and safer practices regarding precaution and vaccination in developing countries.
Team: Carol Isoux (journalist), Agnès Dherbeys (photographer)
Locations: Philippines, Thailand
Media outlets: L’Obs, Marie-Claire, Ouest-France, Europe 1, Loopsider
Budget: 16,760€
This is a story about two young Guineans who came to France to study and write their dissertations on microbiology and infectious diseases. In 2015, when Ebola was running rampant in West Africa, they volunteered for the French emergency aid organisation Eprus to help their compatriots in need — a life-changing experience. This article will tell the story of the re-integration in their home country, with the purpose of creating a workable, sustainable healthcare system. It’s an example that could encourage the repatriation to developing countries.
Team: Estelle Saget (journalist), Alain Tendero (photographer/videographer)
Location: Guinea
Media outlets: The Conversation France, La Croix
Budget: 11,970€
Two years after the end of the Ebola epidemic in West Africa, and with a new one in DRC, how much progress has been made in the development of new therapies? We will investigate the origins of the vaccines and drugs used today, their testing during the epidemics, and why these efforts are key to the world’s biosecurity.
Team: Emmanuel Freudenthal (journalist), Chloé Hecketsweiler (journalist)
Locations: Guinea, Sierra Leone, Liberia
Media outlets: Le Monde, IRIN
Budget: 15,790€
Telemedicine is bringing new hopes to disabled people in developing countries whose rehabilitation is held back by lack of infrastructure and financial means. In Togo, Handicap International conducts a pilot project to reduce the costs of equipment and to help people who live in remote or dangerous areas.
Team: Elodie Bécu (reporter), Jérôme Citron (co-reporter)
Location: Togo
Media outlets: EBRA presse, CFDT Magazine
Budget: 7,410€
Millions of people around the world are affected by sickle cell anaemia. However, the disease is rather unknown, difficult to detect and hardly treated in various countries in Western Africa. Four maternity hospitals in Burkina Faso launched a pilot project in 2015 for neonatal screening. This is the first project of its kind in Burkina Faso, where an estimated 2% of the population is diagnosed with sickle cell anaemia.
Team: Aurélie Franc (journalist), Camille Rioual (video journalist)
Location: Burkina Faso
Media outlet: Le Figaro
Budget: 8,626€
Tuberculosis rages in Uganda, one of the world’s most affected countries by this disease. Tuberculosis is a lethal disease unless it is treated at an early stage. This year, researchers from the University of Bordeaux have launched TB-speed, a four-year programme aimed at screening children from remote areas for tuberculosis to detect it at an early stage and to compensate the healthcare deficits in the country’s infrastructure.
Team: Coralie Lemke (journalist)
Location: Uganda
Media outlet: L’Usine Nouvelle
Budget: 5,256€
This project will explore the issue of antibiotic resistance in India. This country leads an increasing worldwide antibiotic consumption and shows one of the highest disease burden due to antibiotic resistance.
Team: Lise Barnéoud (journalist), Alice Bomboy (journalist, photographer)
Location: India
Media outlet: Le Monde
Budget: 14,000€
Only half of the 300 million people suffering from depression worldwide benefit from treatment, in some developing countries the number only reaches 10%. Particularly in Africa, a western and not always adequate approach to psychology has created a medical vacuum and a taboo around mental diseases. In Senegal and Zimbabwe, local initiatives are emerging which are better suited for the detection and which offer treatments better adapted to the economic, social and cultural context.
Team: Klervi Le Cozic (journalist), Elsa Dorey (journalist), Eugénie Baccot (photographer)
Locations: Senegal, Zimbabwe
Media outlets: We Demain, Paris Match Afrique, Slate, L’Actualité Nouvelle-Aquitaine
Budget: 16,145€
Diabetes is a silent killer in Africa, and fatality is rising. Through lack of information, screening and even medicine, patients die quickly. While international financing is more oriented towards transmitted diseases, some local actors are taking initiative. Telemedicine and health at work could be efficient measures.
Team: Stéphany Gardier (journalist), Olivier Prieur (director/cameraman)
Location: Ivory Coast
Media outlets: Le Figaro, Loopsider
Budget: 13,460€
If you are a freelancer or a journalist on staff who publishes in German media, you can apply for a similar global health reporting grant worth 15,000€ on average. The deadline for submissions is 11 July 2018.
More info about the grant & application form here.
If you have questions about your application, sign up for an “ask me anything” one-on-one Skype session on Wednesday, 27 June by writing an email to healthreporting@journalismgrants.org.
To stay up-to-date about the Journalism Grants activities and other EJC initiatives, sign up for one of our newsletters or read our other articles
How to write stories on development that people actually want to read
Cross-border journalism: The successful example of a German-Indian collaboration
How journalists are overcoming the challenges of global health reporting
Some common mistakes when applying for a journalism grant — and how to avoid them
*Source (in French): Le Monde, 8 February 2018